| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-08 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-08 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-08 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |